Effectiveness of Cognitive Behavioral Therapy on Multi-drug Resistant Tuberculosis Patients in Mongolia: 10 years experiences

Authors

  • Dorjmaa Dashdavaa Department of Mental Health, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia https://orcid.org/0000-0002-4776-3174
  • Bolor Rash Tuberculosis clinic, National Center for Communicable Diseases, Ulaanbaatar, Mongolia
  • Ser-Od Khuyagaa Department of Epidemiology and Biostatistics, School of Public Health, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Anuzaya Purevdagva Department of Communicable Diseases Control, World Health Organization, Mongolia
  • Kyung Hyun Oh Department of End TB, World Health Organization Regional Offi ce for the Western Pacifi c, Philippines
  • Oyunsuren Davaasuren Department of Mental Health, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Naranzul Dambaa Tuberculosis Surveillance and Research Department, National Center for Communicable Diseases, Ulaanbaatar, Mongolia
  • Baatarkhuu Oidov Department of Infectious Diseases, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Khishigsuren Zuunnast Department of Mental Health, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

DOI:

https://doi.org/10.24079/cajms.2024.02.002

Keywords:

Tuberculosis, Depression, Anxiety, Mental health, Psychotherapy

Abstract

Objective: During multidrug-resistant tuberculosis (MDR-TB) treatment, patients face de­pression and anxiety. This study aims to evaluate the effects of cognitive behavioral therapy (CBT) on the psychological status and risk of loss to follow-up (LTFU) during MDR-TB treat­ment in Mongolia. Method: Eligible participants were randomly assigned to intervention and control groups. Intervention group participants underwent CBT, while control group par­ticipants received standard patient education. Psychological status was assessed before and after CBT. MDR-TB treatment outcomes were evaluated as internationally defined. Results: The study included a total of 83 patients. After CBT, depression and anxiety levels decreased by 12% and 16%, respectively, in the intervention group, whereas the control group showed a 4% decrease in depression and an 8.5% increase in anxiety levels. MDR-TB treatment outcomes revealed an 8% higher treatment success rate and a fivefold reduction in LTFU rate in the intervention group compared to the control group. In multivariable logistic regression, risk factors associated with increased LTFU were living alone (OR 12.7, p=0.031) and not being provided CBT (OR 16.1, p=0.040). Conclusion: Our study suggests that CBT not only alleviates these psychological challenges but also diminishes the risk of LTFU during treat­ment, leading to improved MDR-TB treatment success.

Downloads

Download data is not yet available.
Abstract
143

Author Biography

Dorjmaa Dashdavaa, Department of Mental Health, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

Tuberculosis Surveillance and Research Department, National Center for Communicable Diseases, Ulaanbaatar, Mongolia

References

1. Tedros AG. Global tuberculosis report 2023. Geneva, Switzerland: World Health Organization. 2023.

2. WHO consolidated guidelines on tuberculosis. Module 4: Treatment-drug-susceptible tuberculosis treatment. World Health Organization. 2022.

3. Borgil U, Sharkhuu G, Erkhembayar B, et al. Mongolian tuberculosis annual report. Ulaanbaatar, Mongolia: Toonot print;P76-80

4. Auer C, Mazitov R, Makhmudov A, et al. Factors contributing to drug-resistant tuberculosis treatment outcome in five Eastern Europe and Central Asia countries. Monaldi Arch Chest Dis. 2020;90:1235. https://doi.org/10.4081/monaldi.2020.1235

5. Rehm J, Samokhvalov AV, Neuman MG, et al. The association between alcohol use, alcohol use disorders, and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:1-12. https://doi.org/10.1186/1471-2458-9-450

6. Tupasi TE, Garfin AMCG, Kurbatova EV, et al. Factors associated with loss to follow-up during treatment for multidrug-resistant tuberculosis, the Philippines, 2012–2014. Emerg Infect Dis. 2016;22(3):491. https://doi.org/10.3201/eid2203.151788

7. Ragan E, Kleinman M, Sweigart B, et al. The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2020;24(1):73. https://doi.org/10.5588/ijtld.19.0080

8. Santha T, Garg R, Frieden T R, et al. Risk factors associated with default, failure, and death among tuberculosis patients treated in a DOTS program in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002;6(9):780-788.

9. Soedarsono S, Mertaniasih NM, Kusmiati T, et al. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects. BMC Pulm Med. 2021;21(1):1-8. https://doi.org/10.1186/s12890-021-01735-9

10. Johnston JC, Shahidi NC, Sadatsafavi M, et al. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. Plos one. 2009;4(9):e6914. https://doi.org/10.1371/journal.pone.0006914

11. Kendall EA, Theron D, Franke MF, et al. Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug-resistant tuberculosis treatment in rural South Africa: a retrospective cohort study. PLoS One. 2013;8(12):e83480. https://doi.org/10.1371/journal.pone.0083480

12. Kurbatova EV, Taylor A, Gammino VM, et al. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis. 2012;92(5):397-403. https://doi.org/10.1016/j.tube.2012.06.003

13. Ho J, Byrne AL, Linh NN, et al. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bull World Health Organ. 2017;95(8):584. http://doi.org/10.2471/BLT.17.193375

14. Kaliakbarova G, Pak S, Zhaksylykova N, et al. Psychosocial support improves treatment adherence among MDR-TB patients: experience from East Kazakhstan. TOIDJ. 2013;7(1). http://doi.org/10.2174/1874279301307010060

15. Dashdavaa D. Psychosocial current situation among multi-drug resistant tuberculosis patients. Master`s thesis. Mongolia National University of Medical Sciences; 2019.

16. Thurber S, Snow M, Honts CR. The Zung self-rating depression scale: convergent validity and diagnostic discrimination. Sage journals. 2002;9(4):401-405. https://doi.org/10.1177/1073191102238471

17. Dunstan DA, Scott N. Norms for Zung’s self-rating anxiety scale. BMC psychiatry. 2020;20(1):1-8. https://doi.org/10.1186/s12888-019-2427-6

18. Reinert DF, Allen JP. The alcohol use disorders identification test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272-279. https://doi.org/10.1111/j.1530-0277.2002.tb02534.x

19. Fagerstrom K-O, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159-182. https://doi.org/10.1007/BF00846549

20. Dashdavaa D, Zuunnast Kh, Davaasuren O, et al. Cognitive behavioral therapy for multi-drug resistant tuberculosis patients. Ulaanbaatar Mongolia: Admon print; 2020;P3-100

21. MOH. The procedure of organizing TB care and services. Ulaanbaatar, Mongolia: Toonot; 2017;P47-48

22. Raykov T. Scale reliability, Cronbach’s coefficient alpha, and violations of essential tau-equivalence with fixed congeneric components. Multivariate Behav Res. 1997;32(4):329-353. https://doi.org/10.1207/s15327906mbr3204_2

23. Suhadev M, Thomas BE, Murugesan P, et al. Alcohol use disorders (AUD) among tuberculosis patients: a study from Chennai, South India. Plos one. 2011;6(5):e19485. https://doi.org/10.1371/journal.pone.0019485

24. Weiangkham D, Umnuaypornlert A, Saokaew S, et al. Effect of alcohol consumption on relapse outcomes among tuberculosis patients: A systematic review and meta-analysis. Front Public Health. 2022;10:962809. https://doi.org/10.3389/fpubh.2022.962809

25. Slama K, Tachfouti N, Obtel M, et al. Factors associated with treatment default by tuberculosis patients in Fez, Morocco. EMHJ. 2013;19(8):687-693.

26. Zuunnast Kh. Primary care and services of Mental health. Ulaanbaatar, Mongolia: Selenge press; 2023.P10-15

27. Theingi P, Kamiya Y, Moe MM, et al. Depression and its associated factors among people with multidrug-resistant tuberculosis in Myanmar. Trop Med Int Health. 2021;26(9):1117-1126. https://doi.org/10.1111/tmi.13637

28. Walker I, Khan AM, Khan AM, et al. Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: a large cross-sectional study. Int J Tuberc Lung Dis. 2018;22(7):773-778. https://doi.org/10.5588/ijtld.17.0788

29. Morris MD, Quezada L, Bhat P, et al. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient’s perspective. Int J Tuberc Lung Dis. 2013;17(7):954-960. https://doi.org/10.5588/ijtld.12.0480

30. Walker I, Kanal S, Baral S, et al. Depression and anxiety in patients with multidrug-resistant tuberculosis in Nepal: an observational study. Int J Tuberc Lung Dis. 2019;9(1):42-48. https://doi.org/10.5588/pha.18.0047

31. Bhaware G, Quazi Z, Muneshwar M. Assessment of Mental Status of MDR Patients in Wardha District Using Global Mental Health Assessment Tool-Primary Care Version. JAIR. 2014;3(6):274. https://doi.org/10.5588/pha.18.0047

32. Vega P, Sweetland A, Acha J, et al. Psychiatric issues in the management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2004;8(6):749-759.

33. Zuo X, Dong Z, Zhang P, et al. Cognitive-behavioral therapy on psychological stress and quality of life in subjects with pulmonary tuberculosis: a community-based cluster randomized controlled trial. BMC Public Health. 2022;22(1):2160. https://doi.org/10.1186/s12889-022-14631-6

34. Kaliakbarova G, Pak S, Zhaksylykova N, et al. Psychosocial support improves treatment adherence among MDR-TB patients: experience from East Kazakhstan. TOIDJ. 2013;7:60-64. https://doi.org/10.2174/1874279301307010060

35. Harrison RE, Shyleika V, Falkenstein C, et al. Patient and health-care provider experience of a person-centered, multidisciplinary, psychosocial support and harm reduction program for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus. BMC Health Serv Res. 2022;22(1):1-12. https://doi.org/10.1186/s12913-022-08525-x

36. Janmeja A, Das S, Bhargava R, et al. Psychotherapy improves compliance with tuberculosis treatment. Respiration. 2005;72(4):375-380. https://doi.org/10.1159/000086251

37. Khanal S, Elsey H, King R, et al. Development of a patient-centered, psychosocial support intervention for multi-drug-resistant tuberculosis (MDR-TB) care in Nepal. PloS one. 2017;12(1):e0167559. https://doi.org/10.1371/journal.pone.0167559

38. Baral SC, Aryal Y, Bhattarai R, et al. The importance of counseling and financial support to patients receiving treatment for multi-drug resistant TB: mixed method qualitative and pilot intervention studies. BMC Public Health. 2014;14(1):46. https://doi.org/10.1186/1471-2458-14-4

Published

2024-06-30

How to Cite

Dashdavaa, D., Rash, B., Khuyagaa, S.-O., Purevdagva, A., Oh, K. H., Davaasuren, O., … Zuunnast, K. (2024). Effectiveness of Cognitive Behavioral Therapy on Multi-drug Resistant Tuberculosis Patients in Mongolia: 10 years experiences. Central Asian Journal of Medical Sciences, 10(2), 47–56. https://doi.org/10.24079/cajms.2024.02.002

Issue

Vol. 10 No. 2 (2024)

Section

Articles

License

Copyright (c) 2024 Mongolian National University of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.